Ziopharm Oncology reported $21.23M in Current Liabilities for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
AstraZeneca AZN:LN 22594M 1055M
Corcept Therapeutics CORT:US $ 47.54M 2.78M
Eleven Biotherapeutics EBIO:US $ 8.47M 3.09M
Immunogen IMGN:US $ 84.12M 16.83M
Intrexon XON:US $ 28.99M 0.12M
IONIS PHARMACEUT IONS:US $ 241M 38.78M
Novartis NOVN:VX SF 30208M 328M
Sangamo Biosciences SGMO:US $ 118.53M 9.36M
Tg Therapeutics TGTX:US $ 65.38M 22.27M
Verastem VSTM:US $ 16.89M 3.35M
Ziopharm Oncology ZIOP:US $ 21.23M 5.19M